Is Hormone Replacement Therapy Being Applied Too Uniformly?
Menopause care has advanced. Awareness is higher. Prescriptions are rising. Yet many women still report inconsistent results from HRT, limited follow-up and uncertainty about whether their treatment is truly personalised.
In 'Beyond One-Size HRT', we examine a critical question in modern women’s health:
Are we still applying a standardised hormone therapy model to biologically diverse women?
Leading authourities including the North American Menopause Society, NICE and the British Menopause Society are clear. Hormone replacement therapy should be individualised based on age, timing since menopause, cardiovascular risk, symptom profile and medical history.
Research shows absorption of transdermal estrogen can vary significantly between women. Timing of initiation alters risk profile. Route of delivery changes clotting risk. Ethnic disparities persist in prescribing patterns.
The science calls for precision. Not panic. Not uniformity.
If you are navigating perimenopause, menopause or HRT decisions, this is essential reading.
Read the full blog here: https://www.nbwn.org/post/beyond-one-size-hrt
If personalised menopause care matters to you, like this post to extend its reach. Comment with your experience or questions because shared knowledge strengthens collective confidence.
Save it for later reference. Share it with a woman who deserves informed, adaptive care.
